Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L23a pseudogene 74 (RPL23AP74) is a non-protein-coding pseudogene located on human chromosome 17q23.2. It shares sequence similarity with the functional ribosomal protein L23a gene but does not produce a functional ribosomal protein. Unlike functional ribosomal protein L23a, which forms part of the ribosome, RPL23AP74 has no known protein-coding capacity or direct cellular role. There is no evidence that RPL23AP74 is involved in human disease, signal transduction, or therapeutic targeting. However, some ribosomal protein pseudogenes have been recently explored for potential regulatory roles as non-coding RNAs, although there are currently no data supporting such a function for RPL23AP74 itself[1][4][7][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L23a pseudogene 74 (RPL23AP74).